Qrativ
Cambridge
About Qrativ
Qrativ is a developer of a drug purposing platform designed to reinvent the way treatments for diseases with unmet medical need are discovered and developed. The company's platform ,Darwin.ai, identifies new uses for existing molecules for diseases with unmet medical need and uses machine learning and artificial intelligence for research and development, enabling patient to get treatments for diseases for which drugs are not available in the market.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $8.3M
- Funding stage: Early Stage Venture
- Last round: Series A (Jul 2017)
- Website: qrativ.bio
- Phone: [email protected]
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Machine Learning, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/qrativ-184622 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.